Any notice the ridiculous short leash he has his new kid cfo on. Wonder if this kid is even a CPA. Learning finance 101 as he goes. Carter was a fool but I think this kid is just inezperience. But then again who else would take that role.
Hmmm, I don't think you said anything addressing my point, then tossed out acronyms rather than speaking clearly and referenced your doctorate? Rather than using acronyms (to sound smarter?) a post can be digested more quickly by everyone if you just use plain text. That is if your point is to convey information rather than obsfuscate someone else's post.
I never stated nor implied that any purchaser would expect to not have any expenses with the purchase or future operations. I clearly and corrected to the previous poster that a purchaser would not 'break even'. But the numbers show that there isn't much money to be made by purchasing Elite (or by Elite for that matter) and that we need new drugs in our portfolio soon to be more attractive to future investors and possible acquirers.